• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    G

    Gifu Prefectural General Medical Center

    EST. 1909
    1,105论文总数
    1.3万引用总数

    论文量&引用量时间轴

    机构学者

    论文(1105)

    年份
    起
    –
    止
    排序
    1Maternal Safety Outcomes of Respiratory Syncytial Vaccination During Pregnancy with a Large-Scale Database
    Taito Kitano, Toshiyuki Sado,Shinya Tsuzuki,Haruhisa Fukuda,Sayaka Yoshida

    This retrospective cohort study evaluated the risk of maternal safety outcomes, including preterm birth, following prefusion F protein (RSVpreF) during pregnancy compared with an unvaccinated cohort using large-scale real-world data. Propensity score matching was performed to compare the risks of preterm delivery, hypertensive disorder of pregnancy (HDP), gestational diabetes (GDM), oligohydramnios, placental abruption, intrauterine growth restriction (IUGR), and intrauterine fetal death (IUFD) to calculate the odds ratio (OR). Following the propensity score matching, 11,265 and 11,265 pregnant women with and without RSVpreF vaccination were included, respectively. After matching, the ORs in the vaccinated group compared with the unvaccinated group were 0.98 [0.84–1.14], p = 0.789; 1.01 [0.96–1.08], p = 0.644; 0.98 [0.90–1.06], p = 0.570; 0.77 [0.63–0.95], p = 0.015; 0.99 [0.77–1.27], p = 0.949; 0.94 [0.86–1.03], p = 0.189; and 0.68 [0.38–1.22], p = 0.189 for pre-term delivery, HDP, GDM, oligohydramnios, placental abruption, IUGR, and IUFD, respectively. Maternal RSV vaccination did not increase the risk of selected maternal outcome events. However, further safety monitoring with larger sample size is required to detect rare events or small risk differences.

    2026npj Vaccines(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Immediate or On-Demand Endoscopic Necrosectomy for Necrotizing Pancreatitis: A Randomized Controlled Trial (WONDER-01).
    Tomotaka Saito,Toshio Fujisawa,Takeshi Ogura,Masaki Kuwatani,Hiroshi Ohyama,Mamoru Takenaka,Shinpei Doi,Keisuke Iwata,Shinichi Hashimoto,Hideki Kamada,Takuji Iwashita,Hideyuki Shiomi,

    BACKGROUND & AIMS:The optimal timing for direct endoscopic necrosectomy (DEN) after endoscopic ultrasound (EUS)-guided transmural drainage of symptomatic necrotizing pancreatitis remains unknown. We hypothesized that immediate DEN after EUS-guided drainage might reduce the time to disease resolution compared with a drainage-oriented step-up approach. METHODS:This study was a multicenter, open-label, superiority randomized trial (WONDER-01). Among patients who received EUS-guided treatment for symptomatic necrotizing pancreatitis, eligible patients were randomly assigned 1:1 to receive either immediate DEN or the drainage-oriented step-up approach. The primary endpoint was the time from randomization to clinical success, defined as a decrease in collection size to ≤3 cm and an improvement in inflammatory markers. RESULTS:Seventy patients were enrolled in this study: 33 in the immediate DEN arm and 37 in the step-up arm. Immediate DEN was associated with a shorter time to clinical success than the step-up approach (P = .009), with median times (95% confidence interval) of 29 (19-34) and 44 (38-52) days, respectively. All patients in the immediate DEN arm received DEN compared with 46% in the step-up approach arm, but the rates of procedure-related adverse events were comparable (24% vs 22%, respectively; P = .79). No significant differences were noted between the treatment arms in terms of technical success (100% vs 97%; P > .99) and mortality (12% vs 5.4%; P = .41). CONCLUSIONS:Compared with the step-up approach, immediate DEN after EUS-guided drainage of necrotizing pancreatitis reduced time to clinical success without increasing adverse outcomes but required more DEN procedures (ClinicalTrials.gov, NCT05451901).

    2026Gastroenterology(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3Characteristics of Early-Onset, Rapidly Progressive Scoliosis in Spinal Muscular Atrophy Type I Treated with Disease-Modifying Therapy -a Multicenter Retrospective Study Conducted in Japan.
    Tomokazu Kimizu, Reiko Arakawa, Mikiko Hasegawa, Tomoko Mizuno, Ryosuke Bou,Emiko Kobayashi,Toshio Saito,Kazuhiro Muramatsu, Yoshi-Ichiro Kamijo,Tamaki Kato, Kenji Inoue, Mitsuo Motobayashi,

    In the era of disease-modifying therapy (DMT), almost all patients with spinal muscular atrophy (SMA) type I treated after onset, but before 6 months of age, develop early-onset, rapidly progressive scoliosis by 2 years of age, despite improvements in their motor function. Seven symptomatic patients with SMA type I who were treated before the age of 6 months were included in this retrospective observational study. Scoliosis had developed in all patients by 27 months of age. Among them, the patients who could stand with support or independently (standing patients; n = 3) tended to present with more progressive scoliosis than the sitters (n = 4). All standing patients demonstrated thoracic hyperkyphosis before or at the time of their scoliosis diagnosis. Despite receiving DMT, these patients continued to show residual key manifestations of SMA type I. Chronic difficulty maintaining posture due to trunk muscle weakness in the lying, sitting, or standing position was considered to be the main contributor to the development and progression of the scoliosis. The development and progression of such scoliosis, which begins in infancy, may be related to inappropriate postural management, which is not currently recognized as such by clinicians, caregivers, or guardians. In this population, it is important to closely monitor patients for such scoliosis from soon after the diagnosis of SMA. As this type of scoliosis progresses rapidly during the early developmental stage, when surgery is not possible, it is necessary to establish a proactive non-surgical management strategy for it.

    2026Journal of neuromuscular diseases(2026)
    引用
    AI阅读
    加入学术空间
    4Association of Estimated Glomerular Filtration Rate Slopes with Cardiorenal Outcomes in Patients with Chronic Kidney Disease Before and after Multidisciplinary Education
    Masaru Matsui,Maiko Kokubu,Masatoshi Nishimoto,Takaaki Kosugi,Masahiro Eriguchi,Ken-Ichi Samejima,Kazuhiko Tsuruya

    Introduction: Multidisciplinary education has been shown to slow the progression of chronic kidney disease (CKD) and reduce cardiovascular (CV) risk, although its effects depend partly on patient characteristics. The aim of this study was to assess how patients categorized on the basis of estimated glomerular filtration rate (eGFR) responded to multidisciplinary education in terms of cardiorenal outcomes. Methods: In this retrospective cohort study, we included 447 CKD patients who received multidisciplinary education between January 1, 2013, and December 31, 2020, at Nara Prefecture General Medical Center. Exposure was four categories according to eGFR slopes before and after multidisciplinary education. The primary outcomes were renal events defined as the composite of dialysis initiation, transplantation, and 30% eGFR decline, and CV events defined as the composite of heart failure requiring hospitalization, coronary or leg revascularization, cardiac sudden death, and stroke. Results: Multidisciplinary education decreased the median eGFR slope from -5.00 to -0.65 mL/min/1.73 m2/year. In fully adjusted models, the hazard ratios (95% confidence intervals) for total renal events relative to slow-slow eGFR decline were 1.02 (0.50-2.06) for fast-slow decline, 5.30 (2.82-9.97) for slow-fast decline, and 7.53 (4.02-14.1) for fast-fast decline. Only fast-fast eGFR decline was associated with a high risk of CV events. Subgroup analyses showed similar trends. Fast decline after education was independently associated with increased proteinuria and decreased hemoglobin levels. Conclusions: Fast eGFR decline after but not before multidisciplinary education was significantly associated with renal and CV events in CKD patients. Attention should be paid to CKD patients with limited benefit from multidisciplinary education.

    2026Kidney & blood pressure research(2026)
    引用
    AI阅读
    加入学术空间
    5Growth and Safety Evaluation in Very Low Birth Weight Infants Receiving an Exclusive Human Milk Diet: a Phase III Randomized Control Trial in Japan
    Katsumi Mizuno,Tokuo Miyazawa, Utako Kondo, Toshiya Nishikubo,Yutaka Yamamoto,Yuya Nakano,Takehiko Hiroma,Kazushige Ikeda,Masahiko Murase, Hitomi Jimi,Isamu Hokuto, Masafumi Miyata

    OBJECTIVE:To determine safety and efficacy of exclusive human milk diet (EHMD) for very low birth weight (VLBW, <1500 g) infants. DESIGN:Prospective, controlled, open trial of VLBW infants randomized to EHMD (mother's own milk [MOM]/donor milk [DM] with human milk-based fortifiers) or Standard Diet (MOM/DM with cow milk-based fortifier/formula). Outcomes included superiority of weight gain velocity from birth to 34 weeks gestational age, time to full feeds, and safety. RESULT:In total, 147 infants received EHMD (n = 77) or Standard Diet (n = 70). The EHMD group had superior mean weight gain velocity versus the Standard Diet (13.44 vs 11.96 g/kg/day, p = 0.006) and earlier mean time to full feeds (20.0 vs 25.9 days, p = 0.03); adverse events were not significantly different (32.5% vs 21.4%, p = 0.13). CONCLUSION:EHMD is viable for management of VLBW infants, providing improved growth without reduced safety. TRIAL REGISTRATION AND ID:Japan Registry of Clinical Trials: jRCT2031210384.

    2026Journal of perinatology official journal of the California Perinatal Association(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1105 篇论文

    合作机构(100)

    岐阜大学合作论文 213
    三重大学合作论文 153
    岐阜市民病院合作论文 109
    Gifu University Hospital合作论文 95
    Nara Medical University合作论文 63
    岐阜県立多治見病院合作论文 58
    Ogaki Municipal Hospital合作论文 47
    东京大学合作论文 46
    顺天堂大学合作论文 41
    名古屋大学合作论文 41

    机构统计